DPPA2 Antibody - N-terminal region : FITC (ARP52662_P050-FITC)

Product Specifications

Gene Name

Developmental pluripotency associated 2

Gene Aliases

CT100, PESCRG1, ECAT15-2

Gene ID

151871

Swiss Prot

Q7Z7J5

Accession Number

NP_620170

Host

Rabbit

Reactivity

Human, Rat

Immunogen

The immunogen is a synthetic peptide directed towards the N terminal region of human DPPA2

Target

DPPA2 may play a role in maintaining cell pluripotentiality. ECSA/DPPA2 is a promising target for antigen-specific immunotherapy in non-small cell lung cancers.

Partner Proteins

HHV8GK18_gp81; SDCBP2; PBXIP1; MOAP1; DPPA4; SPOP; ZNF250; ZCCHC10; SETD5; DPPA2; MCM10; VTA1; FXR2; PLOD3; DVL2; DVL3; AP2M1; U2AF2

Clonality

Polyclonal

Conjugation

FITC: Fluorescein Isothiocyanate

Type

Polyclonal Antibody

Applications

Purification

Affinity Purified

Concentration

0.5 mg/ml

Homology

Human: 100%; Rat: 90%

Format

Liquid. Purified antibody supplied in 1x PBS buffer.

Reconstitution

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.